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Using the theoretical domains framework to identify barriers and enabling 
factors to implementation of guidance for the diagnosis and management of 
non-alcoholic fatty liver disease: A qualitative study  
 
Background: NAFLD is the most common liver condition worldwide and is steadily on the 
increase. In response, national and international guidance have been developed to standardise 
diagnosis and guide management of the condition. However, research has highlighted a 
discordance between published guidance and clinical practice.  
Purpose: To identify barriers and enabling factors to implementation of guidance to inform 
the development of an intervention. 
Methods: We interviewed 21 healthcare professionals and 12 patients with NAFLD. Topic 
guides were developed with reference to national and international guidance. Data were 
content analysed using the Theoretical Domains Framework. 
Results: Beliefs about consequences and professional role and identity were the most 
prominent domains identified from healthcare professionals in the context of diagnosis and 
management of NAFLD. Environmental context and resources, memory, attention and 
decision processes, goals, behavioural regulation, knowledge and skills emerged as important 
barriers/facilitators to implementation of guidance targeting management of NAFLD. 
Knowledge and beliefs about consequences were the most prominent domains from the 
perspective of patients. Social influences, environmental context and resources and 
behavioural regulation were most prominent in the context of NAFLD management.  
Conclusions: Guideline implementation can be improved by use of interventions that target 
standardised use of diagnostic criteria by healthcare professionals. Training of healthcare 
professionals was identified as important to improve care delivered to patients in order to 
effectively manage NAFLD. Interventions that target knowledge of patients, in particular, 
raising awareness that NAFLD can be progressive when not actively managed would 
facilitate implementation of guidance.  
Keywords: Non-alcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis 
(NASH); Type 2 diabetes (T2D); Theoretical Domains Framework (TDF); Qualitative 
Interviews; Guideline Implementation 
 
 
2 
 
Background 
Non-alcoholic fatty liver disease (NAFLD) is the most common liver condition worldwide 
and is largely associated with dietary excess, inactivity and being overweight. Its prevalence 
is estimated to be 20-30% of the adult population [1,2] and this increases substantially in 
people with Type 2 diabetes mellitus (T2DM) or those with multiple features of the metabolic 
syndrome [3]. In the absence of specific approved pharmaceutical agents for NAFLD, 
changes to diet and increases in physical activity/exercise to achieve weight loss is the 
principal therapeutic recommendation [4,5]. Evidence supporting the use of lifestyle 
interventions is strong and has shown clinically significant reductions in liver fat and 
improvements in glucose control/insulin sensitivity in those with NAFLD [6 -17]. Liver 
inflammation and fibrosis can also be improved/reversed with a weight loss of ≥7-10% and 
research reports a dose-response relationship between weight loss percentage and overall 
histological changes, with the greatest improvements in liver health observed in individuals 
who achieve the greatest weight loss [17]. 
In response to the evidence on the effectiveness of lifestyle interventions for the management 
of NAFLD, the European Clinical Practice Guidelines [18], and the National Institute for 
Health and Clinical Excellence (NICE) Guidelines [19] were published in 2016 followed by 
the American Association for the Study of Liver Disease Guidelines published in 2018 [20]. 
All highlight the importance of lifestyle behaviour change in all patients with NAFLD 
regardless of disease severity. However, despite the publication of these guidelines, a gap 
remains between recommended clinical care behaviours and actual care delivery [21]. 
Specifically, there are inconsistencies in the way in which patients are diagnosed. For 
example, different tools are used to make a diagnosis and in some cases validated tools are 
not used at all. This often leads to inappropriate referrals to secondary and tertiary care. In 
terms of NAFLD management, the majority of patients are monitored for disease progression 
on an annual basis, but not actively managed – i.e. patients are rarely given the information 
and support they require to make lifestyle behaviour changes.     
In terms of NAFLD diagnosis, national and international guidelines [18, 19, 20] suggest that 
when a NAFLD diagnosis is considered likely and based on the patient’s lifestyle and 
medical history, disease severity should be assessed. In the first instance, a non-invasive 
validated tool such as the NAFLD Fibrosis Score or FIB4 [22, 23] is recommended. If there 
is a doubt regarding the diagnosis or if the patient is triaged to be at an indeterminate/high 
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risk of advanced disease, they should be referred to a specialist physician in 
secondary/tertiary care (usually a hepatologist or gastroenterologist) for further investigation. 
At all points in this care pathway patients could benefit from lifestyle intervention regardless 
of disease severity.  
Targeting NAFLD with lifestyle behaviour change is essential to improve patient health, 
particularly as excess liver fat is an independent risk factor for the development of T2DM and 
cardiovascular disease [3]. Despite the accumulating evidence supporting the use of lifestyle 
interventions for the management of NAFLD [24], currently there is no defined clinical 
lifestyle pathway [25]. This would involve the provision of evidence-based lifestyle 
behaviour change intervention and support imbedded in to clinical practice as a referral 
pathway or as part of routine consultations.  
This aim of this qualitative study was to identify barriers and enabling factors to 
implementation of guidance for the diagnosis and management of NAFLD. Specifically, we 
aimed to explore with healthcare professionals’ ways in which the diagnostic process could 
be improved in order to ensure patients are appropriately referred, and to identify how 
patients could be best supported to make lifestyle behaviour changes. We also obtained 
patient views on how to improve the diagnostic process and subsequent management of 
NAFLD. Obtaining the views of both healthcare professionals and patients was considered 
important to establish which areas should be the focus of intervention that meets the needs of 
both groups.  
The guideline recommended practice behaviours of interest were the diagnosis of NAFLD; 
referral of patients following diagnosis; and management of NAFLD (i.e. targeting diet and 
physical activity behaviours of patients to initiate weight loss).  
Methods 
This study was approved by the NHS London-Riverside Research Ethics Committee (REC 
reference: 15/LO/0815). Informed written consent was obtained from healthcare 
professionals and patients by a member of the research team prior to the conduct of the study. 
Patients were reimbursed costs for travel to the Clinical Research Facility where interviews 
took place.  
Three members of the research team have received formal academic training in qualitative 
research methods. Two members of the team are health psychologists who are experienced in 
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the conduct of qualitative research, specifically in the context of intervention development 
and implementation. 
Design and setting 
We conducted semi-structured interviews with healthcare professionals including 
hepatologists, gastroenterologists, diabetologists, practice nurses, general practitioners and 
patients with NAFLD across primary, secondary and tertiary care settings in Newcastle upon 
Tyne, UK. 
Interview topic guides 
Two topic guides (one for healthcare professionals and one for patients) were used to conduct 
the interviews and each was developed with reference to national [19] and international 
guidelines [18] for the diagnosis and management of NAFLD. Each topic guide included 
open ended questions to elicit perceptions on barriers and facilitators to guideline 
implementation (see Additional Files 1 and 2). 
Participants 
We employed a purposive sampling strategy, maximal variation [26] in order to identify 
shared patterns in the data generated from healthcare professionals and patients. 
Healthcare professionals: We recruited healthcare professionals from specialties including 
hepatology, gastroenterology, diabetology and general practice to gain a range of 
perspectives. These clinical specialties were chosen as healthcare professionals were likely to 
see patients with NAFLD on a regular basis. It was also considered important to obtain the 
views from both hospital and community based clinicians working across specialist and 
generalist services. As such, healthcare professionals from two NHS Hospitals Trusts and 11 
UK NHS clinical commissioning groups were invited to take part in the study. Invitations 
were sent via email or by verbal invitation. Healthcare professionals were interviewed by a 
member of the research team.  
Patients:  We recruited a sample of adults aged ≥18 years with a diagnosis of NAFLD 
identified by review of medical records by primary and secondary care teams. Patients were 
invited to take part in the study by letter. We aimed to recruit a sample of patients taking in to 
account age, gender, length of time since diagnosis and those who had attended appointments 
in primary and/or secondary/tertiary care settings. Those who were interested in taking part 
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were asked to contact the research team directly to arrange an interview. The research team 
did not have any influence on patient recruitment. Patients were subsequently interviewed by 
one member of the research team. 
Methods to maximise trustworthiness of data 
A number of established methods were used to maximise the trustworthiness of the data 
generated and subsequent themes reported. These included triangulation of data sources (i.e. 
interviews with primary and secondary healthcare professionals and patients) and analysts 
(i.e. data were independently coded by two researchers) to enhance credibility; and provision 
of a thick description to add context supported by direct quotes to enhance transferability. 
Dependability and confirmability were enhanced by the development of a coding system and 
transparent reporting of the conduct of the study, including data analyses and interpretation 
[27].   
Analysis 
Data generated from interviews were analysed using the Theoretical Domains Framework 
(TDF) [28]. The TDF was developed to simplify and integrate 33 behaviour change theories 
and 128 key theoretical constructs related to behaviour change. These were synthesised into a 
single framework to assess implementation and clinical behaviours around evidence-based 
guidelines and therefore appropriate for use in the current qualitative study. The TDF 
originally comprised of 12 domains, which was subsequently validated and refined to 14 
domains. These are knowledge, skills, social/professional role and identity, beliefs about 
capabilities, optimism, beliefs about consequences, reinforcement, intentions, goals, memory, 
attention, and decision processes, environmental context and resources, social influences, 
emotion, and behavioral regulation. The 14 domain framework was used for the purpose of 
this study.  
All interviews were audio-recorded and transcribed verbatim. A three-stage process was 
followed in order to analyse interview transcripts of both healthcare professionals and 
patients. Firstly, two interview transcripts (one healthcare professional and one patient 
transcript) were pilot-coded independently by two researchers to agree a coding strategy (i.e. 
to ensure both researchers were coding consistently and to discuss and resolve any difficulties 
when applying the TDF). Initial findings of the two pilot transcripts were discussed before 
coding the remaining transcripts. Secondly, data from the remaining transcripts were 
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independently coded by the same two researchers and this involved reading and re-reading 
transcripts, coding the content into themes and subthemes and mapping these, with 
supporting direct quotes, to an appropriate theoretical domain of the TDF [28] (see Table 1 
and Table 2). Although the TDF was used as a coding framework, code generation outside of 
the TDF was possible to ensure all data generated were coded and reported. Finally, a 
discussion took place to agree the most prominent domains as barriers and facilitators to 
implementation of guidance. Judging the most prominent domains is customary within TDF 
guided analyses [29] in order to provide suggestions for which domains should be target for 
intervention. These were identified based upon the following criteria: (i) the frequency in 
which specific views or beliefs within each domain were expressed by participants; and (ii) 
the strength of views or beliefs within each domain that were discussed at great length. 
Illustrative quotes were used to support domains and sub-themes within domains.  
Given the explicit nature of the TDF as the guide for coding, all interview transcripts were 
coded and analysed by hand and no qualitative software was required. In line with published 
guidance, interview transcripts were analysed until the point of data saturation – i.e. 
interviews with healthcare professionals and patients ceased once data saturation had been 
reached. Data saturation was considered for healthcare professionals and patients separately – 
i.e. no further interviews were conducted within each of these groups once data saturation had 
been reached. Data saturation was assumed when subsequent interviews did not lead to the 
identification of additional barriers and facilitators, or differing views on previously 
identified barriers and facilitators [30].  
 
Results 
Twenty-one healthcare professionals (10 male;11 female) were recruited from primary (n=7) 
and secondary/tertiary care (n=14) settings. Eleven were consultants specialising in 
hepatology (n=4); gastroenterology (n=4); and diabetology (n=3); six were primary care 
physicians; two were dieticians; one a hepatology specialist nurse and one a primary care 
practice nurse.  
Twelve patients (8 male; 4 female; aged 58.9 years [range 44-72 years]) were recruited from 
primary (n=8) and secondary/tertiary care settings (n=4).  The average time since diagnosis 
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was 3.9 years (range 1 month to 19 years). Two of the eight patients recruited from primary 
care had also attended appointments in secondary/tertiary care.  
Interviews with healthcare professionals lasted approximately 20 minutes (range: 7-32 
minutes) and patient interviews approximately 10 minutes (range: 5-17 minutes). 
Healthcare professional perspectives 
Nine theoretical domains were identified in relation to barriers and facilitators to guideline 
implementation from the perspective of healthcare professionals. In terms of NAFLD 
diagnosis, optimism and beliefs about consequences were identified. In terms of NAFLD 
management, beliefs about consequences, memory, attention and decision processes, 
professional role and identity, knowledge, skills, goals, behavioural regulation and 
environmental context and resources were identified (See Table 1).  
The most prominent domain identified for both diagnosis and management of NAFLD was 
beliefs about consequences.   
 
NAFLD Diagnosis and referral 
Optimism 
Healthcare professionals felt that the introduction of local guidance for the diagnosis of 
NAFLD had worked well to increase the number of appropriate referrals from primary to 
secondary/tertiary care (i.e. patients referred did on the whole require secondary/tertiary care 
specialist input). “Guidelines are now more widely used, actually we get quite a lot that come 
[to Secondary Care] with a NAFLD Fibrosis Score already calculated and have done all the 
tests…. So the new guidelines have made a big difference”.  It was also believed that primary 
care professionals may only be referring patients they are most concerned about or those 
whose condition had progressed from mild NAFLD to a more serious form of liver disease 
(i.e. Nonalcoholic steatohepatitis [NASH] with significant fibrosis). Although the 
implementation of local guidance was considered beneficial for diagnosing patients, variation 
in guideline adherence was noted and that some inappropriate referrals remained. It was 
therefore reported that greater awareness was required around the need to use validated tools 
to diagnose and standardised training on how to use them. It was also considered important to 
raise awareness of when it is appropriate to refer to secondary/tertiary care (e.g., when more 
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serious forms of NAFLD are diagnosed and require specialist input). Overall, healthcare 
professionals were optimistic that with appropriate training on the use of guidance and 
awareness raising that the diagnostic process could be improved. 
Beliefs about consequences 
Following diagnosis of NAFLD in primary care, secondary healthcare professionals reported 
patients having very little or no understanding of their diagnosis when attending secondary 
care appointments. The majority indicated that information should be provided at the time of 
diagnosis.  However, some primary healthcare professionals believed that providing 
information at this time could lead to an increase in anxiety in patients because some “don’t 
want to know about it or hear about it, and other people get quite anxious about it” 
Therefore, NAFLD was regularly ‘played down’ by healthcare professionals.  
NAFLD Management 
Beliefs about consequences 
Healthcare professionals reported providing advice to patients to lose weight and exercise 
more in order to manage their NAFLD, but emphasised that patients often did not follow this 
advice – i.e. it was believed that time spent providing lifestyle advice would not be 
worthwhile. Although it was acknowledged that patients lacking knowledge about their 
condition was one possible explanation for why advice was not acted upon.  
Professional role and Identity 
In terms of NAFLD management, there was a general consensus among healthcare 
professionals that the condition was actively monitored rather than managed (i.e. patients 
were seen usually on an annual basis where they would undergo a series of tests to assess 
disease stage and progression). “I don’t think I would ever enter into the situation where I’m 
ever actually managing their weight loss or fatty [liver]” The belief was that it was not the 
role of the specialist to target lifestyle behaviour change. Although some reported providing 
advice to lose weight. 
Environmental context and resources 
Healthcare professionals reported that limited time during consultations meant that lifestyle 
behaviour change could not be fully addressed, particularly when patients lacked knowledge 
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about what NAFLD is and how it can be managed. In addition, lack of available lifestyle 
support resources within clinics and external services for referring patients to meant that 
healthcare professionals were restricted in terms of the extent to which they could adequately 
target lifestyle behaviour change. It was felt that greater awareness of local lifestyle services 
was required so that patients could be referred for support outside of the clinical setting: it 
would be “fantastic to be able to send them to something in the community”. 
Knowledge 
Where services to refer patients to were not available, it was reported that knowledge and 
skills of the clinical team should be targeted with training. It was highlighted that some 
primary healthcare professionals lacked specific knowledge about NAFLD and reported 
difficulties in being able to communicate to patients what it is, the risks associated with it and 
how it can be managed. It was also felt that the clinical team lacked knowledge and skills in 
lifestyle behaviour change, or where this expertise did exist (e.g., in secondary care it was 
reported that a member of the clinical team did have expertise in this area), it was not feasible 
for one individual within a team to manage the large number of patients being referred. It was 
emphasised that knowledge and expertise in the context of lifestyle behaviour change within 
the clinical team was required to offer a multidisciplinary team approach NAFLD 
management. 
Skills 
The majority of healthcare professionals felt that they were not adequately trained to 
effectively target lifestyle behaviour change themselves and as such suggested that training in 
this area would be beneficial, “I think if you were looking for what little things could make a 
difference within a much more limited budget then having some form of training on 
intervention, motivational interviewing would be really helpful” 
Goals 
Healthcare professionals felt that it was important to set patients goals as a means of 
‘nudging’ them towards increased levels of physical activity and exercise and to reduce 
calorie consumption. It was felt that graded goals would be most effective to ensure that the 
changes were realistic and could be sustained in the long-term. 
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Behavioural regulation  
A number of healthcare professionals suggested that “food diaries, [and] pedometers to set 
people simple goals…to nudge people towards slightly greater exercise and nudge people 
slightly lower calorific intakes” would be useful. This would allow patients to track their 
progress against dietary and activity goals in order to change their lifestyle behaviours. Other 
suggestions included an online programme containing information and advice about diet, 
exercise and the psychological aspects of making lifestyle changes. Others suggested new 
ways of communicating to patients about what their liver looks like compared to how it 
should look using models to help regulate behaviour. All agreed that monitoring of lifestyle 
behaviours was important.  
Memory, attention and decision processes 
Healthcare professionals reported management of patients with NAFLD to involve 
monitoring rather than active lifestyle management and that the decision-making process was 
informed by local guidance. For example, if a patient had an abnormal liver function test, 
primary healthcare professionals reported using the guidance to make a decision on whether 
to refer to secondary care.  Whereas secondary care professionals reported referring to the 
guidance to make decisions on referring patients back to primary care for monitoring.  
 
Patient perspectives 
Four theoretical domains were identified in the context of guideline implementation from the 
perspective of patients. These were knowledge, beliefs about consequences, social influences 
and behavioural regulation (see Table 2). Knowledge and beliefs about consequences were 
the most prominent domains identified in relation to diagnosis and management of NAFLD. 
NAFLD Diagnosis and referral 
Knowledge 
When interviewed patients were mostly concerned about the diagnostic process and the need 
for clear information about NAFLD, “I would have liked for it to have been explained how or 
why you get it, because they don’t really”. It was emphasised that there was a lack of 
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information about the risks associated with it, and whether it is something to be concerned 
about.  
Beliefs about consequences 
Diagnosis of NAFLD was reported by patients as being unexpected and usually a 
consequence of being investigated for something else. “It was only when I went for a visit, 
routinely, to the GP, for something completely different, that she said, ‘We have discovered 
that you have got this, and we need to do a blood test”. Following diagnosis, patients reported 
being told by healthcare professionals that NAFLD was nothing to worry about, particularly 
when other co-morbid conditions such as T2DM existed (i.e. that these were the priority). 
This meant that patients did not go in search for information about the condition themselves 
(e.g., from the internet) or feel the need to consider management approaches. 
NAFLD Management 
Knowledge 
When asked about the management of NAFLD, patients found it difficult to provide their 
views on what they believed would be helpful due to not knowing exactly what NAFLD was 
and how it could be managed. They reported a lack of basic information about NAFLD when 
diagnosed, particularly in terms of whether it is something they should be concerned about, 
whether it could/should be managed, and if so how. ““They tell you very little really.  You 
know, you just get told that you’ve got fatty liver disease, but they’ll say a lot of people have 
fatty liver disease, it’s nothing to worry about”. This finding alone was considered a barrier 
to implementation of guidance in terms of NAFLD management. This was reinforced by 
healthcare professionals who believed that patients’ lack of knowledge may have prevented 
them from acting upon lifestyle behaviour change advice given to them by members of the 
clinical team.  
Social Influences 
Patients reported being monitored for disease progression, but emphasised a lack of 
information and support thereafter. Support was reported to consist of advice to lose weight 
and exercise more, however this advice was rarely taken particularly in situations where 
patients were told that NAFLD was nothing to worry about. 
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Behavioural regulation 
Patients found it difficult to provide suggestions to facilitate management of NAFLD in 
general, largely due to lack of information about what NAFLD is, how its progresses and 
optimal management approaches. However, when lifestyle behaviour change was mentioned, 
dietary plans and monitoring of diet and physical activity progress by a healthcare 
professional was reported as something that would be beneficial, “Yes, yes, like even if it was 
just monthly monitoring, with a diet plan and a target”. In terms of physical activity, patients 
suggested that a pedometer would be a useful tool to allow them to check and monitor their 
own progress. 
A summary of barriers from the perspective of healthcare professionals and patients is 
presented in Table 3 with suggestions for intervention. These suggestions are based on our 
expert opinion as authors with expertise in the development of interventions in the context of 
health and lifestyle behaviour change. 
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Table 1. Barriers and facilitators to diagnosis and management of NAFLD in the context of guideline implementation from the perspective of healthcare 
professionals  
Theme/Subtheme Illustrative quotation Theoretical domain(s) assigned 
to subtheme 
1.0 Diagnosis of NAFLD 
1.1 Sub-theme: Local 
guidelines have improved the 
diagnostic process 
“Guidelines are now more widely used, actually we get quite a lot that come [to Secondary Care] 
with a NAFLD Fibrosis Score already calculated and have done all the tests and then it's a just liver 
biopsy. So the new guidelines have made a big difference. Not everyone's using them yet but I think 
if we give it a couple of years, simple intervention will have made a huge difference”  
Optimism 
1.2 Sub-theme: Inconsistent 
use of diagnostic criteria in 
primary care leads to 
variability in the 
appropriateness of referrals 
“Very few (patients) that I’ll see once, discharge and say, this is a waste of everybody’s time… 
probably the GPs are actually filtering out a lot of the ones that are thought to be just simple 
steatosis…maybe the GPs are looking after lots of people that we might want to get hold of and 
might want to stage the disease properly. So maybe they’re only referring in the ones that they’re 
most worried about and there’s another cohort that we’re never seeing…” 
“The risk of NAFLD is recognised in the community. The NAFLD fibrosis score is calculated and 
then for example, patients with indeterminate or high scores are passed on to Secondary and Tertiary 
Care. The reality is that in some practices that is exactly what happens, which is excellent. In other 
practices, it is completely ad-hoc. Patients may be referred on with the most minor changes in liver 
biochemistry. And similarly, patients with more significant changes may not be referred on” 
Beliefs about consequences 
1.3 Sub-theme: Patients have 
little or no understanding of 
their diagnosis  
[patients are] “told they have a problem with their liver [by a GP]. Many of them, unless it’s been 
properly explained to them by the GP are puzzled why that is because they associate liver disease 
with alcohol consumption” 
“We’ve got a population of people…that I don’t think know that they’ve got this diagnosis… 
historically, it’s not really been something we’ve been proactive about doing anything with..” 
Beliefs about consequences 
1.4 Sub-theme: Diagnosis of 
NAFLD may initiate anxiety 
in patients 
“People who really didn’t want to know about it or hear about it [NAFLD diagnosis], and other 
people obviously get quite anxious about it. And I suspect sometimes we maybe play the condition 
down a little bit…” 
Beliefs about consequences 
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 “I think that a proportion of these people are worried that they have got cancer, and that is why they 
have sought, you know, depending on why they were originally had investigations, they still anxious 
to seek reassurance”  
2.0 Management of NAFLD  
2.1 Sub-theme: Referring to 
local guidelines inform 
decision making about 
management approach 
“if somebody has abnormal LFTs…refer to the (local) guidelines at about what level you should then 
go on to refer and what level you would just monitor in general practice…need to be on the lookout 
that they’re not going to develop further specific liver problems” 
Memory, attention and decision 
processes 
2.2 Sub-theme: Monitoring 
of the condition is more likely 
than active management 
“I would see them more with a chronic liver disease slant. I don’t think I would ever enter into the 
situation where I’m ever actually managing their weight loss or fatty…Yes, I wouldn’t ever…I’m not 
sure I could really afford to get too involved in the, kind of, active management of risk factors and 
stuff. I would definitely shun that back to primary care or to the patients themselves to be honest. I’m 
quite keen on getting the patient to take the responsibility”  
 “So if you score as high risk or if your biopsy shows that you’ve got fibrosis then you’re somebody 
that we’re going to monitor for complications of cirrhosis. So those people will go into…we’ll keep 
hold of them for a six-monthly review and they’ll get the HCC surveillance so they’ll get their 
ultrasound six-monthly…They’ll get endoscopies at appropriate intervals” 
Professional role and identity 
2.3 Sub-theme: Training is 
required to improve 
knowledge, diagnosis and 
management of NAFLD 
“Increasing education of GPs is the primary thing. If we can get them to follow the guidelines we've 
published, actually we are 95% of the way there, because they will recognise abnormal LFTs and 
they will start to do the right things and intervene or whatever and identify the sick patient” 
“Probably under treat and under monitor most of these people. We’re very aware that there’s lots and 
lots of people have mildly abnormal liver function tests that we never really go into great detail, as 
long as it’s stable. So I think there probably is a training need there to know who it is we should be 
looking at and when we should be referring them on” 
“The problem with NAFLD is diagnosing it and I think the lack of treatment specific for NAFLD is 
the biggest problem…we’re still coming back to telling them to exercise and lose weight…” 
 “I think the lack of understanding in primary care is very evident sometimes and a lot of them 
[patients] come very angry because they've been accused of drinking alcohol” 
Knowledge 
Skills  
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 “I think it [increased knowledge] would be beneficial the fact that when they start to ask me 
questions at least possibly I could give them an answer rather than saying, you need to speak to the 
GP about that one” 
2.4 Sub-theme: Training to 
effectively target lifestyle 
behaviour change is required  
“in terms of assessing weight loss readiness, there could be a little bit more work done with that, 
prior to, um, the patients working with me in the clinic…good identification of those [patients] that 
are ready to make those changes…makes a huge difference to your outcomes in your care plan and in 
your work” 
 “Skills of motivational interviewing and behaviour change are probably where I think there is still an 
awful lot of people telling people what to do. And that culture needs to change 
“I think if you were looking for what little things could make a difference within a much more 
limited budget then having some form of training on intervention, motivational interviewing would 
be really helpful. Because actually if you can improve the skills of the people who are seeing the 
patients then it’s more helpful than doing nothing and it’s less reliant on… Someone else doing it. 
And I think it probably would help if you’re referring to something like an exercise programme you 
have to have got somebody on board with that, don’t you? 
Beliefs about consequences  
Skills 
2.5 Sub-theme: A 
multidisciplinary team with 
the necessary expertise is 
required to successfully 
implement guidance on the 
management of NAFLD 
NAFLD service “very focused on one aspect of lifestyle…we  don’t  have  anyone  who’s  
specialised  in  giving  physical activity…a  good  proportion  of  patients  who  just  don’t  know  or  
don’t  know  what  to  do  or  don’t  know  how  they  can  adapt  certain  things  and,  yes,  so   that  
would  be  a  major  part  of  the  clinic  that’s  missing” 
“Multi-disciplinary team…Dietetics…key to delivery. Work on lifestyle change…individuals who 
develop NAFLD…are not particularly open to increasing exercise…individuals with fatty liver lack 
the confidence to make these changes…giving some advice and enabling people to make those 
changes would be useful…psychological support…not uniformly available…” 
“What I ideally wanted was almost like a one-stop shop… I can foresee a great big clinic with me, 
the physio, a dietician, all doing a one-stop appointment for them to go out” 
Beliefs about consequences  
Environmental context and 
resources 
Skills 
2.6 Sub-theme: Tools and 
resources are needed to 
support management of 
NAFLD 
“Food diaries, pedometers to set people simple goals…to nudge people towards slightly greater 
exercise and nudge people slightly lower calorific intakes. It doesn’t have to be traumatic, in fact the 
less traumatic it is the easier it will be to sustain it” 
“online thing where patients can, kind of, log in, they can track their progress, there is loads of advice 
about exercise, diet, psychology, all that sort of thing…pedometers…HR monitors…Fitbits” 
Behavioural regulation  
Environmental context and 
resources 
Goals 
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“a simple patient information leaflet”  
“Some kind of liver with fat in it and inflammation on it and scarring so I could actually say, "This is 
what a liver should look like and this is what happens to your liver."  
2.7 Sub-theme: There is no 
treatment for NAFLD other 
than lifestyle advice  
“I mean that’s the trouble with non-alcoholic fatty liver disease. Apart from lifestyle, there’s not a lot 
else to do [treatment wise]...”  
 “normally you just tell them to  lose  10% of  their  weight  and  that’s  it.  There's no treatments”  
Beliefs about consequences 
2.8 Sub-theme: Lack of 
awareness of external lifestyle 
services 
“Not really sure what’s involved (in making a referral to other lifestyle services)…It’s not something 
I’m aware of being available…if it is that would be good.” 
 “I genuinely don’t know where to send them…go and speak to the GP because they’ll have more 
knowledge than I have”  
Knowledge 
2.9 Sub-theme: The option to 
refer to an external lifestyle 
service would facilitate 
management of patients with 
NAFLD 
“What has grabbed me most is the idea of being able to prescribe interventions, and order up 
pedometers… I would like to be able to send someone to a service…what I would like, is to be able 
to pass the patient on to some sort of lifestyle coach, and then for the next time I see them to have 
more data, so that I can look at what their calorie intake, and what their eating habits is, what their 
pedometer shows, what their self-filled questionnaire about their self-efficacy….  
“Pretty much every patient I see could do with some sort of lifestyle coaching of some description, 
tailored to them, be it alcohol or weight management or IBS or, you know…”  
“fantastic to be able to send them to something in the community”  
 
Environmental context and 
resources 
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Table 2: Barriers and facilitators to guideline implementation from the perspective of patients  
 
 
Theme/Subtheme Illustrative quotation  
1.0 Diagnosis of NAFLD Theoretical domain(s) assigned 
to subtheme 
1.1 Sub-theme: Diagnosis of 
NAFLD was unexpected 
 “It was only when I went for a visit, routinely, to the GP, for something completely different, that she 
said, ‘We have discovered that you have got this, and we need to do a blood test’. Did the blood test, 
and then she said, ‘I am going to refer you’, which I was quite shocked at, because I wasn’t expecting 
anything to become of it. Because it had been quite a while. And then she referred me to [the 
hospital], for a liver biopsy.”  
Beliefs about consequences 
 
1.2 Sub-theme: Information 
provision following diagnosis 
of NAFLD is lacking 
“I couldn’t really go into it. It was so brief, what I got off my GP. And I haven’t done much research 
into it myself.  She did tell me I could Google it [NAFLD] and read up about it…But I haven’t.”  
“They tell you very little really.  You know, you just get told that you’ve got fatty liver disease, but 
they’ll say a lot of people have fatty liver disease, it’s nothing to worry about – lots of people live all 
of their lives, well, most of their lives with fatty liver disease and that’s it.”  
“I would have liked for it to have been explained how or why you get it, because they don’t 
really…by what I have read sometimes it’s your diet and things like that.  And well, just what you 
should do really, just anything…it would be nice to have a leaflet just for it to explain, and things that 
would help.” 
Knowledge 
2.0 Management of NAFLD  
2.1 Sub-theme: NAFLD is 
monitored but not actively 
managed 
“It’s just a matter of monitoring how you get on. Making sure you’re doing what she’s telling you to 
do. The next step would be a consultant, but wouldn’t they give you the same sort of information?”  
 “I had the biopsy, and got the results back from the biopsy to say that they didn’t need to see me 
again – but no help, no advice, no: ‘Okay, you are at the early stages…this is what you need to do so 
that you don’t progress, nothing’.”  
Beliefs about consequences 
2.2 Sub-theme: Support to 
make lifestyle changes to 
manage NAFLD is lacking 
“The only thing they said was to try and sort of lose a bit of weight…But, apart from that, no, I’ve 
never ever had any advice or anything else.”  
“At the time I thought, right okay, does that mean I’m overweight or something?  And then he said, 
“Oh you must drink a lot?”.  And I went, “No, I don’t drink at all”.  They said, oh right.  And that was 
Knowledge 
Beliefs about consequences 
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it.  So they marked that down and that was the end of that really.  He said, “Are you sure you don’t 
drink?”, I went, “No, I don’t drink at all”.  [Laughter].  Can drink cause that?”  
3.2 Sub-theme: Support from 
clinicians and other patients to 
target lifestyle behaviour 
change would be beneficial  
“Some type of intervention in terms of weight loss and dieting might be quite useful. And certainly to 
kind of motivate them to do it regularly. You could have just a kind of nurse in-between seeing the 
doctors in the hospital. Or you could take it into the community if there are so many people who’ve 
got non-alcoholic fatty liver disease, and develop kind of satellite clinics, for which you don’t really 
need a doctor.”  
“I think people work well in groups and support each other, and it is nice to hear other peoples’ 
experiences, I think that group session would be great.”  
“Yes, yes, like even if it was just monthly monitoring, with a diet plan and a target. Which is 
basically Slimming World, which is what I do anyway..” 
“….A pedometer that you bring back with you and you look at… that would be good” 
Social influences 
Environmental context and 
resources 
Behavioural regulation  
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Table 3. Barriers to guideline implementation from the perspective of healthcare professionals and 
patients with suggestions for intervention 
 
Barrier 
 
Suggestion for intervention 
Lack of awareness of guidance for the diagnosis and 
management of NAFLD 
Raise awareness among primary and secondary care 
clinical teams of the availability of clinical 
guidelines 
Variation in guideline adherence Prompt routine use of clinical guidelines and identify 
training needs 
Lack of knowledge of how to use validated tools to 
diagnosis NAFLD 
Provide standardised training for clinical teams  
Patients lack of knowledge of NAFLD and potential 
management approaches 
Provide information to patients at the time of 
diagnosis to include a range of management options 
Patients not following lifestyle advice Emphasise the role of lifestyle behaviour change for 
the management of NAFLD  
Limited time during consultations to adequately 
target lifestyle behaviour change 
Provide training and tools to deliver brief 
intervention targeting lifestyle behaviour change 
Lack of lifestyle behaviour change resources for use 
during consultations 
Provide tools to target lifestyle behaviour change for 
use during consultations  
Lack of external lifestyle behaviour change support 
services 
Identification of and signposting to community 
lifestyle support services  
Healthcare professionals lack of knowledge about 
NAFLD including how it can be managed  
Provide standardised training to clinical teams 
Lack of knowledge and skills of healthcare 
professionals to effectively target lifestyle behaviour 
change 
Provide standardised training to clinical teams 
equipping team members with knowledge and skills 
to target lifestyle behaviour change 
Lack of lifestyle behaviour change expertise in the 
clinical team 
Provide training to all members of the 
multidisciplinary team to facilitate a consistent 
approach 
Lack of support given to patients to make lifestyle 
changes 
Provide training to clinical teams including 
information about community lifestyle support 
services and tools that patients can use beyond the 
clinical consultation 
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Discussion 
We identified nine theoretical domains from the perspective of healthcare professionals that 
were considered either barriers or facilitators to guideline implementation for the diagnosis 
and management of NAFLD. In terms of diagnosis, they included beliefs about consequences 
and optimism. Overall, healthcare professionals believed that local guidance had improved 
NAFLD diagnosis rates (i.e. more patients with NAFLD were being identified) and referral 
rates (i.e. referrals to secondary and tertiary care were increasing) and that referrals were 
more informed and appropriate (i.e. specialist input was required in the majority of cases). 
Therefore, national and international guidance [18-20] had started to make a positive impact 
on practice behaviours. However, findings highlighted that there is a lack of awareness that 
guidelines exist and this has led to inconsistent referral behaviour. The need to raise 
awareness about the availability of diagnostic tools and guidance was emphasised as well as 
the need for standardised training to ensure clinicians are using the guidance correctly (e.g., 
that they use validated tools correctly and consistently).  
Seven theoretical domains were identified in the context of NAFLD management. These 
included beliefs about consequences, memory, attention and decision processes, professional 
role and identity, knowledge, skills, environmental context and resources and behavioural 
regulation. Beliefs about consequences was identified as most prominent in the context of 
NAFLD management, with the majority of healthcare professionals reporting that providing 
lifestyle advice would not make best use of time because patients rarely acted upon advice 
given. Monitoring was initially considered to be important to ensure that patients did not 
develop further liver problems, however when explored further, it was acknowledged that this 
is not an optimal management approach in the context of lifestyle behaviour change. 
Furthermore, many secondary care professionals indicated that it was not their role to address 
lifestyle behaviour change. This emerged as a significant barrier to guideline implementation 
in the context of NAFLD management. Six of these nine domains were identified by a 
previous study that elicited primary healthcare professional’s perspectives on implementation 
of clinical guidelines for diabetes and hypertension [31], and five of these nine domains were 
identified by authors exploring adherence to multiple evidence-based indicators in primary 
care [32] suggesting that commonalities exist across conditions and care settings in the 
context of guideline implementation.  
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Four theoretical domains were identified from the perspective of patients. These were 
knowledge, beliefs about consequences, social influences and behavioural regulation. Two 
domains (knowledge and beliefs about consequences) were identified in relation to NAFLD 
diagnosis. There was a consensus among patients that information provision at the time of 
diagnosis was lacking and management support thereafter was non-existent. Any lifestyle 
advice provided was rarely acted upon by patients because they were advised that NAFLD 
was nothing to worry about.  
In order to improve implementation of guidance for the diagnosis and management of 
NAFLD, the findings of this study highlight the need for interventions to improve the 
diagnostic process and subsequent management approach. We identified a number of 
theoretical domains that if targeted by an intervention have the potential to improve care 
delivery. Findings from patient interviews supported those of healthcare professionals, 
specifically the need for clear information at the time of NAFLD diagnosis for patients and a 
greater awareness among healthcare professionals of diagnostic criteria to ensure appropriate 
referrals are made to secondary and tertiary care. However, it emerged from interviews with 
primary healthcare professionals that they did not feel particularly knowledgeable about 
NAFLD and as such reported difficulties when communicating about the condition to 
patients, particularly around disease progression and management. This in part may explain 
why referrals to secondary and tertiary care were reported as inconsistent in terms of disease 
stage and why diagnostic and management advice was regularly sought from secondary and 
tertiary care professionals.  
The theoretical domains knowledge and skills emerged as barriers to implementation of 
guidance from the perspective of primary and secondary healthcare professionals. Training 
provision to improve knowledge and skills in relation to diagnosis and lifestyle behaviour 
change was frequently reported across interviews, although professional role and identity 
emerged as a barrier in some cases – i.e. secondary/tertiary healthcare professionals in 
particular did not consider it as their role to target lifestyle behaviour change in any 
significant depth during consultations. This could be an area for intervention. The suggestion 
for a dedicated member of the team to take on the role of working with patients to make 
lifestyle behaviour changes was favoured or a process for referring to external community 
lifestyle services. Therefore, environmental context and resources showed to be a significant 
facilitator in the context of NAFLD management and could be a target for intervention.  
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Patients consistently reported a desire to better understand their condition which in turn 
would motivate them to seek and engage with support to self-manage. Interviews with 
healthcare professionals emphasised that patients did not respond positively to management 
advice, however without an understanding of their condition and the potential consequences 
of the diagnosis, it is understandable why patients are less likely to follow advice. Previous 
research has reported a similar finding in the context of engagement with a dietary 
intervention for NAFLD management [33].  
The findings from this qualitative study supports a growing awareness of NAFLD among 
healthcare professionals in the community and the notion that the introduction of local 
guidelines [22] has prompted primary healthcare physicians to assess for NAFLD and refer to 
secondary care when appropriate. Primary healthcare professionals are in general requesting 
an increasing number of blood tests and encountering a rise in abnormal liver function tests 
and diagnoses of NAFLD [25]. Local guidelines appear to have been useful in standardising 
diagnostic testing and have improved the appropriateness of referrals received by secondary 
care teams (i.e. increasingly patients are being triaged in primary care and only those at an 
indeterminate/high risk of advanced disease are being referred to secondary care for specialist 
opinion). Although the data highlight how guidance has impacted positively on healthcare 
professional behaviours, it appears that there are some primary healthcare professionals who 
are not currently following guidelines. This has been reported as lack of awareness of 
NAFLD and/or existence of the guidance and has been identified via this study as an area to 
target with intervention. Findings also highlight the importance of standardising the pathway 
of care within individual medical practices to ensure consistency of care. In the UK, the 
recently published National Institute for Clinical Excellence (NICE) guidelines [19] place 
emphasis on primary care physicians identifying NAFLD in higher-risk patient groups and 
assessing for advanced liver disease (i.e. liver fibrosis) prior to referring to a relevant 
specialist in hepatology. However, these guidelines rely on healthcare professionals being 
aware of and being knowledgeable about NAFLD and the findings of this qualitative study 
suggest that this is not always the case and that there is a clear training requirement.  
Although there have been improvements in the diagnostic process for NAFLD, and the 
findings of this study provide support for this, management of NAFLD appears to be an 
ongoing issue. National and international guidelines recommend lifestyle 
modification/behaviour change for the management of NAFLD [18,19, 20], however these 
guidelines fail to provide specific details regarding how this should or could be achieved. Our 
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findings suggest that current lifestyle management of patients with NAFLD largely consists 
of general advice to lose weight and exercise more with no specific information on how 
patients can achieve this or tailoring of information to individual patient needs or 
circumstances. We were able to explain this by identifying knowledge and skills in the 
context of lifestyle behaviour change from the perspective of healthcare professionals, 
therefore identifying a training need in this regard.  
Strengths and limitations 
 
A strength of this study is that, to the best of our knowledge, it is the first to report on barriers 
and enabling factors to guideline implementation in the context of NAFLD diagnosis and 
management with the aim of identifying targets for intervention. The findings report several 
issues with the diagnostic, referral and lifestyle management procedures and practices, but 
also provides suggestions from healthcare professionals and patients about how national and 
international guidelines could be implemented and thus care delivery improved. 
 
Interview topic guides were developed with reference to published guidelines for the 
diagnosis and management of NAFLD and not based on the TDF. The advantage of this 
approach was that study participants (healthcare professionals and patients) were encouraged 
to respond to questions about diagnosis and management of NAFLD in relation to guidelines 
and not to questions specifically related to each theoretical domain (i.e. questions and 
responses were more focussed and closely linked to practice). Although, there was no 
response generated by the topic guide that could not be linked to a domain within the TDF, 
emphasising the comprehensiveness of the framework used.  
A further strength of this study was that both healthcare professionals and patients were 
interviewed. This allowed us to explore barriers and facilitators to guideline implementation 
from the perspectives of both groups and identify consensus. The approach was successful in 
this regard.  
Interviews with healthcare professionals and patients were of relatively short duration which 
could be considered a limitation. However, it is likely that this reflects the lack of knowledge 
of primary healthcare professionals in particular and the lack of knowledge and awareness 
patients had in relation to their diagnosis. It is also possible that it reflects the little contact 
time patients have with healthcare professionals with regards to NAFLD and as such they had 
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limited experiences to report. It was reassuring that data generated from patients supported 
data generated by healthcare professionals.  
 
Healthcare professionals and patients were recruited to this study from a single region of 
Europe (north-east England) with a high prevalence of NAFLD. Given the regional variation 
of service provision, it is possible that the views and experiences reported may not be 
representative nationally or internationally. However, steps were taken to ensure that a 
purposive sample of healthcare professionals and patients receiving treatment in primary, 
secondary and tertiary care, from multiple providers and healthcare professionals from 
specialist and generalist services were recruited. We believe that this approach increased the 
transferability of findings. 
 
Conclusions 
Barriers to guideline implementation for NAFLD diagnosis included lack of awareness of 
local guidance and training of healthcare professionals to use validated tools; and lack of 
information provision to patients. Barriers to NAFLD management included knowledge and 
skills of healthcare professionals to effectively support patients to make lifestyle changes, 
although professional role was also considered a barrier with many secondary healthcare 
professionals reporting lifestyle behaviour change as not part of their role. A lack of 
resources and the belief that patients would fail to enact on lifestyle advice was also 
considered a barrier. Barriers to NAFLD management from the perspective of patients 
included lack of knowledge and awareness of what NAFLD is, whether it is progressive and 
how it should or could be managed. Facilitators to implementation of guidance included 
awareness raising with healthcare professionals about the availability of local guidance for 
making a diagnosis and training on how to effectively use it. Information provision for 
patients at the time of diagnosis was believed to be a facilitator to engagement with NAFLD 
management. Facilitators to NAFLD management included training for clinical teams, or as a 
minimum, training of a designated individual within a team to target lifestyle behaviour 
change in patients; provision of intervention resources to support lifestyle behaviour change 
during consultations; online programmes to support patients to manage their condition 
outside of clinical appointments and external lifestyle services to provide additional support 
to patients in the community. Patients were not able to provide a lot of information 
concerning NAFLD management due to lack of knowledge about what NAFLD is and how it 
can be managed, but indicated that support to make lifestyle changes and tools to be able to 
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monitor progress would be beneficial. The findings of this study will inform the development 
of an intervention for healthcare professionals and patients with an emphasis on guideline 
implementation and optimisation of care delivery pathways for people with NAFLD.  
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